Neuropeptide Y polymorphism significantly magnifies diabetes and cardiovascular disease risk in obesity: the Hoorn Study. - Jaakkola U; Kallio J; Heine RJ; Nijpels G; T' Hart LM; Maassen JA; Bouter LM; Stehouwer CD; Dekker JM (European Journal of Clinical Nutrition, 2009)